Open Access
| Issue |
Radioprotection
Volume 60, Number 1, January-March 2025
|
|
|---|---|---|
| Page(s) | 91 - 98 | |
| DOI | https://doi.org/10.1051/radiopro/2024042 | |
| Published online | 14 March 2025 | |
- Barquero R, Basurto F, Nunez C, et al. 2008. Liquid discharges from patients undergoing 131I treatments. J Environ Radioact 99: 1530–1534. [CrossRef] [PubMed] [Google Scholar]
- China Atomic Energy Agency, Ministry of Science and Technology, Ministry of Ecology and Environment et al.2021. Medium and long-term development plan for medical isotopes. Available from: https://www.caea.gov.cn/n6760338/n6760342/c6831058/content.html. [Google Scholar]
- Clarke SEM. 1994. Radioiodine therapy of the thyroid. In Murray IPC, Ell PJ, eds. Nuclear Medicine in Clinical Diagnosis and Treatment pp. 833-845. Edinburgh: Churchill Livingstone. [Google Scholar]
- Department of Radiation Source Safety Regulation, Ministry of Ecology and Environment. 2023. Reply to Consultation on Several Clauses of the Nuclear Medicine Standard (Radiation Notice (2023) 20th). Available from: https://www.mee.gov.cn/xxgk2018/xxgk/sthjbsh/202309/t20230913_1040761.html [Reply to Consultation on Several Clauses of the Nuclear Medicine Standard]. [Google Scholar]
- Driver I, Packer S. 2001. Radioactive waste discharge quantities for patients undergoing radioactive iodine therapy for thyroid carcinoma. Nucl Med Commun 22: 1129. [CrossRef] [PubMed] [Google Scholar]
- Esser JP, Krenning EP, Teunissen JJM, et al. 2006. Comparison of [(177)Lu-DOTA(0),Tyr(3)]octreotate and [(177)Lu-DOTA(0),Tyr(3)]octreotide: which peptide is preferable for PRRT? Eur J Nucl Med Molec Imag 33: 1346–1351. [CrossRef] [PubMed] [Google Scholar]
- General Administration of Quality Supervision, Inspection and Quarantine of the People’s Republic of China.2002. Basic standards for protection against ionizing radiation and for the safety of radiation sources: GB 18871. Beijing: Standards Press of China. [Google Scholar]
- State Bureau of Environment Protection, General Administration of Quality Supervision, Inspection and Quarantine. 2005. Discharge Standard of water pollutants for medical organization: GB 18846. Beijing: Standards Press of China. [Google Scholar]
- ICRP.1991. Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Oxford: Pergamon Press. [Google Scholar]
- ICRP. 2004. Release of Patients after Therapy with Unsealed Radionuclides. Ann. ICRP 34. DOI: 10.1016/j.icrp.2004.08.001 [Google Scholar]
- International Atomic Energy Agency, Pan American Health Organization, World Health Organization. 2002. Radiological Protection for Medical Exposure to Ionizing Radiation: IAEA Safety Standards Series No. RS-G-1. 5. Vienna:International Atomic Energy Agency. [Google Scholar]
- Kwekkeboom DJ, Bakker WH, Kooij PP, Konijnenberg MW, Srinivasan A, Erion JL, Schmidt MA, Bugaj JL, de Jong M, Krenning EP. 2001. [177Lu-DOTA0, Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients. Eur J Nucl Med 28: 1319–1325. [CrossRef] [PubMed] [Google Scholar]
- Levart D, Kalogianni E, Corcoran B, et al. 2019. Radiation precautions for inpatient and outpatient 177Lu-DOTATATE peptide receptor radionuclide therapy of neuroendocrine tumours. EJNMMI Phys 6: 7–7. [CrossRef] [PubMed] [Google Scholar]
- Ministry of Ecology and Environment of the People’s Republic of China. 2021. Radiation Protection and Safety Requirements for Nuclear Medicine: HJ 1188—2021. Beijing: Environmental Science Press. [Google Scholar]
- US Nuclear Regulatory Commission. 1997. Regulatory Guide 8. 39, Release of Patients Administered Radioactive Materials. Washington, DC: US Government Printing Office. [Google Scholar]
- Ward WF. 2006. Basic principles of radiation biology. In: Henkin R. E., Bova D., Dillehay G. L. et al. (Eds.) Nuclear Medicine pp. 507-522. Philadelphia: MOSBY ELSEVIER. [Google Scholar]
- Wyszomirska A. 2012. Iodine-131 for therapy of thyroid diseases. Physical and biological basis. Nuclear Medicine Review for Central and Eastern Europe 15: 120–123. [Google Scholar]
- Zaknun JJ, Bodei L,Mueller-Brand J et al. 2013. The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. Eur J Nucl Med Molec Imag 40: 800–816. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.